China Isotope & Radiation (HKSE:01763) Debt-to-Equity : 0.36 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Debt-to-Equity?

China Isotope & Radiation's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$238 Mil. China Isotope & Radiation's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$1,617 Mil. China Isotope & Radiation's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$5,133 Mil. China Isotope & Radiation's debt to equity for the quarter that ended in Dec. 2023 was 0.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for China Isotope & Radiation's Debt-to-Equity or its related term are showing as below:

HKSE:01763' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.2 Max: 0.52
Current: 0.36

During the past 9 years, the highest Debt-to-Equity Ratio of China Isotope & Radiation was 0.52. The lowest was 0.04. And the median was 0.20.

HKSE:01763's Debt-to-Equity is ranked worse than
63.33% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs HKSE:01763: 0.36

China Isotope & Radiation Debt-to-Equity Historical Data

The historical data trend for China Isotope & Radiation's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Debt-to-Equity Chart

China Isotope & Radiation Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.23

0.19

0.21

0.20

0.36

China Isotope & Radiation Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial											0.21	0.20	0.20	0.23	0.36

Competitive Comparison of China Isotope & Radiation's Debt-to-Equity

For the Medical Devices subindustry, China Isotope & Radiation's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Isotope & Radiation's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's Debt-to-Equity falls into.

China Isotope & Radiation Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

China Isotope & Radiation's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(237.557	+	1616.969)	/	5133.454
	=	0.36

China Isotope & Radiation's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(237.557	+	1616.969)	/	5133.454
	=	0.36

China Isotope & Radiation (HKSE:01763) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

China Isotope & Radiation Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

China Isotope & Radiation (HKSE:01763) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089

Website

https://www.china-isotope.com

China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines